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Summary Scirrhous gastric cancer cells proliferate rapidly with fibrosis, when the cancer cells invade into the
submucosa of the stomach. To investigate the mechanisms responsible for the rapid proliferation, the growth
interaction between gastric cancer cells and fibroblasts was examined. Human gastric cancer cell lines
established from scirrhous carcinoma or well-differentiated adenocarcinoma were used. Human fibroblast cell
lines were obtained from various organs. The growth interaction between gastric cancer cells and fibroblasts
was examined by calculating the number of cancer cells or by measuring [3H]thymidine incorporation of cancer
cells. Gastric fibroblasts specifically stimulated the growth of scirrhous gastric cancer cells, but not that ofwell-
differentiated adenocarcinoma cells. The growth factor(s) produced from gastric fibroblasts were then partially
purified and characterised. The growth-promoting factor(s) had apparent molecular weights of 10 000 dalton
and was sensitive both to heat and proteinase treatment. No inhibition for the factor(s) was achieved with
defined anti-growth factor antibodies. In this study, differential responses of scirrhous and well-differentiated
gastric cancer cells to orthotopic fibroblasts were shown. Rapid proliferation of scirrhous gastric carcinoma
should be partly controlled by orthotopic fibroblasts. The growth factor(s) from gastric fibroblasts, which was
distinct from various defined growth factors such as epidermal growth factor (EGF), basic fibroblast growth
factor (b-FGF), transforming growth factor-a (TGF-a), keratinocyte growth factor (KGF), vascular endothelial
growth factor (VEGF), insulin-like growth factor I (IGF-I), hepatocyte growth factor (HGF), platelet-derived
growth factor (PDGF) and transforming growth factor ,B1 (TGF-,B1) may play an important role in the
progression of scirrhous gastric cancer cells.
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Human scirrhous gastric carcinoma (diffusely infiltrating
carcinoma or Borrman's type IV carcinoma) is characterised
by cancer cell infiltration and proliferation with extensive
fibrosis in the stroma (Tahara, 1990). Although the prognosis
of gastric cancer has recently improved, that of scirrhous
gastric cancer has not (Kiyasu et al., 1981). One of the
reasons for the poor prognosis of this type of cancer is the
difficulty of diagnosing it at an early stage, in part because of
the rapid proliferation of the cancer cells. When scirrhous
gastric cancer cells invade into submucosa of stomach, the
cancer cells proliferate rapidly with fibrosis. The mechanisms
responsible for the rapid proliferation are not understood
clearly. The typical histological findings of scirrhous gastric
carcinoma suggest that its development may be controlled by
intercellular interactions between the cancer cells and the
stroma cells such as fibroblasts. Recently, several studies have
been published on the effect of fibroblasts on the production
of the extracellular matrix of gastric cancer cells (Naito et al.,
1984; Yamamoto et al., 1990). However, there has been no
published report about the growth effect of gastric fibroblasts
on scirrhous gastric cancer cells. Therefore, we examined the
growth interaction between gastric cancer cells and fibro-
blasts derived from different organs, and partly purified and
characterised a growth factor(s) for scirrhous gastric
carcinoma.
Materials and methods
Cell types and cell culture
The human gastric cancer cell lines, OCUM-2M (poorly
differentiated adenocarcinoma) (Yashiro et al., 1995),
OCUM-1 (poorly differentiated adenocarcinoma), KATO-
III (signet-ring cell carcinoma) (Sekiguchi et al., 1978),
MKN-28 (well-differentiated adenocarcinoma) (Hojo, 1977),
MKN-74 (well-differentiated adenocarcinoma) (Hojo, 1977),
were cultivated in medium (see below) in a 100-mm culture
dish (Falcon, Lincoln Park, NJ, USA), and incubated at 37°C
in a humidified atmosphere of 5% carbon dioxide in air.
OCUM-2M, OCUM-1 and KATO-III were derived from
scirrhous gastric carcinoma.
Human fibroblast cell lines were obtained from various
organs. Original organ of each fibroblast cell line is
presented in Table I. A fibroblast cell line, NF-8, and a
scirrhous gastric cancer cell line, OCUM-2M, were obtained
from the same patient (Yashiro et al., 1994). NF-1, NF-Eso,
NF-Je and NF-Co were obtained from the same patient.
The other fibroblast cell lines were derived from different
patients. HS-27F was obtained from the American Type
Culture Collection (Rockville, MD, USA), and the other
fibroblast cell lines were derived from normal tissues of each
organ in our laboratory, as follows. Briefly, each tissue
specimen was excised under aseptic conditions and minced
with forceps and scissors. Pieces of each tissue were
cultivated in medium in a 100-mm culture dish (Falcon)
and incubated in humidified incubators at 37°C in an
atmosphere of 5% carbon dioxide and 95% air. The
fibroblasts gradually grew in a monolayer. When confluent,
the fibroblasts were collected and transferred to another
culture dish every 5-7 days. The fibroblast origin was
verified by immunostaining with two monoclonal antibodies
against vimentin and human fibroblast (Dako, Glostrup,
Denmark).
The culture medium was composed of Dulbecco's modified
Eagle medium (DMEM) (Bioproducts, Walkersville, MD,
USA) with 2% heat-inactivated fetal calf serum (FCS)
(Gibco, Grand Island, NY, USA), 100 IU ml-' penicillin
(ICN Biomedicals, Costa Mesa, CA, USA), 100 Mug ml-'
streptomycin (ICN Biochemicals), 2 mM glutamine (Biopro-
ducts) and 0.5 mm sodium pyruvate (Bioproducts).
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Fibroblast cell line Original organ
NF-8 Stomach
NF-I Stomach
NF-Eso Oesophagus
NF-Je Jejum
NF-Co Colon
NF-Liver Liver
NF-Pa Parotis
NF-Ma Mamma
NF-Ov Ovary
HS-27F Foreskin
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Preparation ofserum-free conditioned media
Serum-free conditioned medium (SF-CM) from fibroblasts
was prepared as follows. 5.0 x 105 fibroblasts were seeded into
100-mm plastic dishes with 10 ml of DMEM containing 2%
FCS, and incubated at 37°C for 3 days. To obtain the SF-
CM, the fibroblasts were washed twice with Dulbecco's
phosphate-buffered saline (PBS) and then incubated for 2
days with 1 ml of DMEM. The number of fibroblasts in each
dish was approximately 2 x 106 cells at the collection of SF-
CM. The SF-CM was collected and centrifuged at 1000 g for
5 min, passed through filters (pore size 0.45 gum; Kurabo,
Osaka, Japan) and stored at -20°C until use. The fibroblasts
were used before the 15th passage in culture. Proliferative
ability measured as doubling time was not different among
the fibroblast cell lines.
Effect offibroblasts on the growth ofgastric cancer cells
The proliferation of the gastric cancer cells was determined
by calculating the number of cancer cells or by measuring
[3H]thymidine incorporation.
The number of cancer cells was calculated following the
addition of SF-CM from fibroblasts using a Coulter counter
(Industrial D; Coulter Electronics, Luton, UK). To determine
the optimal concentration of SF-CM for its growth-
promoting activity, the kinetics and serum dependency of
the activity produced from NF-8 cells were examined by
culturing OCUM-2M cells. OCUM-2M cells were cultured in
24-well plates for 3 days in the presence of varying
concentrations of SF-CM from NF-8 cells. Since the activity
for OCUM-2M was evident following the addition of 25%
SF-CM with 1-2% FCS (see Figure 1), the growth-
promoting assay was conducted at 25% SF-CM. Briefly,
250 jil of SF-CM was added to 750 tl of tumour cell
suspension (1 x 104 cells per well) with 2% FCS in each
well of 24-well dishes, and incubated. The number of cells
was counted at various time points using a Coulter counter.
Serum-free medium instead of active fraction was used as a
control.
The effect of fibroblasts on DNA synthesis of gastric
cancer cells was determined by measuring [3H]thymidine
incorporation. Briefly, 750 ,l of the tumour cell suspension
(1 x 105 cells per well) with 2% FCS was added to 250 Ml of
SF-CM in each well of 24-plates, and incubated with a pulse
of 1 pCi per well of [3H]thymidine (28 Ci mmol-1; Amer-
sham, Tokyo, Japan) for 24 at 37°C. As a control, 250 pl of
DMEM was used. The cells were then rinsed and collected on
a membrane filter, and the radioactivity incorporated into
DNA was determined in a liquid scintillation counter (Aloka,
Tokyo, Japan).
Treatment ofserum-free conditioned medium
The SF-CM obtained from NF-8 was used to characterise the
growth-promoting activity. The growth activity was studied
by culturing OCUM-2M cells as target. For measurement of
heat stability of the growth-promoting activity, SF-CM was
heated to 56°C for 30 min, 80°C for 10 min, and 100°C for
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Figure 1 Proliferative effects of conditioned medium from NF-8
cells on OCUM-2M cells. (a) OCUM-2M cells were cultured for 3
days in the presence of varying doses of the serum-free
conditioned medium with 2% FCS. OCUM-2M cells were
significantly increased following the addition of 10-50% SF-
CM. (b) The growth of OCUM-2M cells with 25% SF-CM (0)
was significantly increased in the presence of 0.3-20% FCS
compared with control (0). The growth activity was evident with
1-2% FCS. The results are presented as the mean of three
samples and the bars indicated the s.d. *P<0.05; **P<0.01 vs
control.
30 min. The susceptibility of the activity to proteases was
examined by incubation of the SF-CM with 1 unit ml-' of
proteases, trypsin (Sigma, St Louis, MO, USA), cx-chymo-
trypsin (Sigma), or proteinase K (Sigma) at 370C for 24 h.
All samples were passed through filters (Kurabo). To
determine whether the growth-promoting factor possessed
heparin affinity, we examined the activity of SF-CM loaded
onto the heparin affinity column ECHONO-Pac heparin
cartridge (Bio-Rad, Richmond, CA, USA). Treated SF-CM
(250 ,ul) was added to 750 Mul of OCUM-2M cell suspension
(1 x 104 cells per well) with 2% FCS in each well of 24-well
dishes, and cultured for 3 days. The growth-promoting
activity of the treated SF-CM was determined by calculating
the number of OCUM-2M cells. The growth-promoting
activity (% control) was calculated as:
Growth - promoting activity (% control)
number of cells cultured in medium with samples 100 -100
number of cells cultured in medium alone
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Figure 2 Effect of SF-CM from fibroblasts on the growth of various cancer cells. SF-CM from gastric fibroblasts (NF-1, NF-8)
significantly increased the number of scirrhous gastric cancer cells (OCUM-2M, OCUM-1, KATO-III) but not that of well-
differentiated adenocarcinoma cells (MKN-28, MKN-74). SF-CM from foreskin fibroblasts (HS-27F) did not stimulate the number
of any cancer cells. The results are presented as the mean of three samples and the bars indicate the s.d. *P<0.01 vs control.
Ion-exchange chromatography
The SF-CM from NF-8 was applied to a TSK-gel DEAE-
5PW column (75 x 7.5 mm; Tosoh, Tokyo, Japan) equili-
brated with PBS. The column was washed with 20 ml PBS
and the bound protein was eluted with a linear gradient of
0-0.8 M sodium chloride in the PBS. Eluted protein was
detected by UV absorption at 280 nm. All manipulations
were carried out at room temperature. Aliquots of 250,l of
each fraction were added to 750 pl of OCUM-2M cell
suspension (1 x 104 cells per well) with 2% FCS in each well
of 24-well dishes, and growth-promoting activity was
determined by calculating the number of cancer cells. Active
fractions (20 ml) were then combined and concentrated to
about 2 ml by ultrafiltration.
Gelfiltration chromatography
The concentrated active fractions were applied to a TSK-gel
G2000SWXL column (300 x 7.5 mm; Tosoh) equilibrated with
PBS. The fractions were collected at a flow rate of
1 ml min-'. The wavelength of the detector was set to
280 nm. All manipulations were carried out at room
temperature. Ferritin (Mr 450 000), bovine serum albumin
(Mr 67 000), ovalbumin (Mr 45 000), chymotrypsinogen A
(Mr 25 000), cytochrom C (M, 12 300) and insulin chain B
(Mr 3500) were used as the standard samples for the
molecular weight calibration. The standard samples were
purchased from Serva Feinbiochemica, Heidelberg, Germany.
An aliquot of 750 Ml of OCUM-2M cell suspension (1 x 104
cells per well) with 2% FCS was inoculated into each well of
24-well plates (Falcon) with a pulse of 250 p1 of each
fraction, and incubated. After 3 days the number of cancer
cells was counted.
Effect ofdefined growth factors on the growth of OCUM-2M
cells
We examined the effect of various defined growth factors,
including EGF (Gibco), b-FGF (Austral Biologics, San
Ramon, CA, USA) KGF (UBI, Lake Placid, NY, USA),
VEGF (Pepro Tec, Rocky Hill, NJ, USA), TGF-a (Becton
Dickinson Labware, Mountain View, CA, USA), IGF-I
(Mallinckrodt, St Louis, MO, USA), PDGF-AA (Austral
Biologicals), HGF (Becton Dickinson Labware), and TGF-
,B1 (King Brewing, Kakogawa, Japan) which are thought to
affect the growth of gastric carcinoma (Yoshida et al., 1989,
1990; Yasui et al., 1988; Tanimoto et al., 1991; Hattori et
al., 1994; Shibamoto et al., 1992; Ito et al., 1992) on the
growth of OCUM-2M cells. An aliquot of 1 ml of OCUM-
2M cell suspension (1.0 x 104 cells ml-') was inoculated into
each well of 24-well plates (Falcon) with various concentra-
tions of the defined growth factors, and incubated. The
number of OCUM-2M cells was counted at various time
points.
Effect ofanti-growthfactor antibodies on the growth activity of
conditioned mediumfromfibroblasts
We used neutralising antibodies for several growth factors
including anti-human EGF antibody (Oncogene Science,
Uniondale, NY, USA), anti-human b-FGF antibody (Wako,
Tokyo, Japan) (Hori et al., 1991), anti-TGF-a antibody
(Pepro Tec), anti-HGF antibody (Sigma), rabbit IgG
standard (Zymed, San Francisco, CA, USA) and mouse
IgG standard (Tago, Burlingame, CA, USA). These
antibodies were reconstituted in 0.1 g BSA per 100 ml of
serum-free medium. Effect of the neutralising antibodies
against their respective ligands was examined in experi-
-Responses of gastric cancer to fibroblasts
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mental study (see Table III). Antibody solutions of 4, 20,
100 and 400,g ml-I were prepared and mixed 1:1 (v/v)
with the peak growth activity fraction 22 by high-
performance liquid chromatography (HPLC) (see Figure
3b). A 500 Ml portion of OCUM-2M cell suspension (1 x 104
cells per well) with 2% FCS was inoculated into each well of
24-well plates (Falcon). Antibody solutions (500 ,ul) were
added to each well and incubated. Final solutions contained
25% fraction sample and antibody concentrations of 1, 5, 25
or 100 Mg ml-'. After 3 days the number of OCUM-2M
cells was counted. Serum-free medium instead of active
fraction was used as a control.
Statistical analysis
Data were analysed statistically using Student's t-test. A P-
value less than 0.05 was considered statistically significant.
Results
Growth-promoting activity ofserum-free conditioned medium
from fibroblasts for various gastric cancer cells
The activity for OCUM-2M cells was evident following the
addition of 25% SF-CM with 1-2% FCS (Figure 1); the
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Figure 3 Effect of SF-CM from fibroblasts on DNA synthesis of gastric cancer cells. (a) The [3H]thymidine incorporation of
OCUM-1 and KATO-III cells was significantly enhanced 130-180% by SF-CM from orthotopic fibroblasts (NF-1, NF-8), while
that of MKN-28 and MKN-74 cells was not enhanced by SF-CM from any fibroblasts. (b) The [3H]thymidine incorporation of
OCUM-2M cells was significantly enhanced 130-150% by SF-CM from orthotopic fibroblasts (NF-1, NF-8) compared with
control, while that of OCUM-2M cells was not enhanced by SF-CM from various ectopic fibroblasts. The results are presented as
the mean of three independent experiments and the bars indicate the s.d. *P<0.05; **P<0.01 vs control.
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growth-promoting assay was then conducted at this
concentration. The three scirrhous gastric cancer cell lines
grew floating but not anchorage dependent in the culture
medium and were not adherent to dishes following the
Table II Biochemical characterisations ofgrowth-promoting activity
in the serum-free conditioned medium from NF-8 cellsa
Growth-promoting
activity
(% control) Inhibition (%)
Heat treatment
Untreated 32
56°C for 30min 11 66
80°C for 10min 2 93.7
100°C for 30min 0 100
Enzyme treatment
Untreated 52
Trypsin (1 unit mlr) 0 100
a-Chymotrypsin (1 unit 0 100
mlr)
Proteinase K (1 unit ml-l) 0 100
Heparin affinity
Before heparin chromato- 48
graphy
After heparin chromato- 45 6
graphy
aSerum-free conditioned medium from NF-8 was subjected to
different treatments as described in Materials and methods. The
addition of the SF-CM. The SF-CM from gastric fibroblasts
(NF-1, NF-8) significantly increased the number of scirrhous
gastric cancer cells (OCUM-2M, OCUM-1, KATO-I1I) after
60 h in culture but not that of well-differentiated adenocarci-
noma cells (MKN-28, MKN-74). The SF-CM from foreskin
fibroblasts (HS-27F) did not increase the number of any
cancer cells (Figure 2). The SF-CM from orthotopic
fibroblasts (NF-1, NF-8) specifically stimulated the DNA
synthesis of scirrhous gastric cancer cells by 130-180%
compared with control, but not well-differentiated adenocar-
cinoma cells. The SF-CM from various ectopic fibroblasts did
not stimulate the DNA synthesis of any type ofgastric cancer
cells (Figure 3).
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Figure 4 Purification of the growth-promoting activity. (a)
Cation-exchange chromatography. The SF-CM from NF-8 was
applied to a TSK-gel DEAE-5PW column. Elution ofprotein was
monitored by absorption at 280 nm. The growth-promoting
activity of each fraction was examined by calculating the number
of OCUM-2M cells. Peak activity was eluted at 160mm sodium
chloride, fractions 9 and 10. (b) Gel filtration chromatography of
the SF-CM from NF-8. The SF-CM was applied to a TSK-gel
G2000SWXL column and eluted with PBS. The growth-promoting
activity was determined by calculating the number of OCUM-2M
cells. Calculated molecular weight of the major peak was 10000
dalton. Arrowheads indicate positions of standard molecular
markers. Molecular weight markers included: ferritin (M,
450000), bovine serum albumin (Mr 67000), ovalbumin (Mr
45000), chymotrypsinogen A (Mr 25000), cytochrom C (M,
12300) and insulin chain B (Mr 3500).
Figure 5 Effect of defined growth factors on the growth of
OCUM-2M cells. (a) OCUM-2M cells were cultured with various
defined growth factors in concentrations ranging from 0.1-
100ngml-', and then cell proliferation was determined by
calculating the number of cancer cells after 72h in culture.
EGF, VEGF, TGF-ac, KGF and b-FGF significantly stimulated
OCUM-2M cell growth in concentrations ranging from 10-
100ngml-1 compared with control cells. IGF-I, PDGF and HGF
had no significant effect on the growth of OCUM-2M cells. TGF-
,B decreased the growth of OCUM-2M cells. (b) OCUM-2M cells
were cultured with O0ngml-1 growth factors, and cell prolifera-
tion was determined at various time points. The growth of
OCUM-2M cells was stimulated by EGF, VEGF, TGF-a, b-FGF
and KGF after 48 h culture. The growth effect was evident after
72h culture. Points, means of three samples and the bars indicate
the s.d.
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Characterisation of the growth-promoting activity
The effects of various treatments on the growth-promoting
activity of the conditioned medium are shown in Table II.
Protein concentrations in SF-CM from fibroblasts were
measured by a Bio-Rad protein assay kit (Bio-Rad,
Richmond, VA, USA) using BSA as a standard. Protein
concentration in each SF-CM was 40.6-49.3 ig ml-' per
2 x 106 cells. The activity was partially lost when heated at
56°C for 30 min and completely lost when heated at 80°C for
10 min. Treatment with trypsin, a-chymotrypsin, or protei-
nase K also destroyed the activity completely. The growth-
promoting activity of SF-CM was retained even after heparin
chromatography (Table II).
Purification of the growth-promoting activity
The SF-CM from NF-8 was applied to a TSK-gel DEAE-
5PW column. Peak activity was eluted at 160 mM sodium
chloride (Figure 4a). The active fractions 9 and 10 were
concentrated and applied to a TSK-gel G2000SWXL column.
A peak of growth-promoting activity was observed in
fraction 22. From calculation of molecular weight of the
polypeptide using the standard samples, it was estimated that
the apparent molecular weight of the major peak was 10 000
dalton (Figure 4b). The growth of MKN-28 cells was not
stimulated following the addition of fraction 22 (data not
shown).
Effect ofdefined growth factors on the growth of OCUM-2M
cells
To identify possible mitogens involved in OCUM-2M cell
growth, we investigated the dose-response relationship
between OCUM-2M cells and defined growth factors,
including EGF, VEGF, TGF-ac, IGF-I, KGF, b-FGF,
PDGF-AA, HGF and TGF-1. OCUM-2M cells were
cultured with these growth factors in concentrations ranging
from 0.1-100 ng ml-. EGF, TGF-oc, VEGF, KGF and b-
FGF significantly stimulated OCUM-2M cell growth in
concentrations ranging from 10 to 100 ng ml-' after 72 h
Table m Bioactivitya of neutralising antibodies against 10ngml-1
of EGF, TGF-a, b-FGF and VEGF
Growth-promoting
activity Bioactivity
Antibody (% control) (% inhibition)
Anti-EGF antibody
Control 29
1 gml'- 26 4
5ggml-1 26 4
25 tgml-1 9 69
Anti-TGF-ax antibody
Control 25
losgml-l 25 0
25 sgml-1 24 4
100 igml-1 3 88
Anti-b-FGF antibody
Control 18
ljgml'- 4 78
Sggml-I 0 100
25ggml
- 0 100
Anti-VEGF antibody
Control 26
lojIgml-1 26 0
25ggml-l 24 8
100jgml-1 6 77
aNeutralising antibodies were mixed with OCUM-2M cells which
were cultured with each growth factor. The growth activity and
bioactivity were determined for OCUM-2M cells as described in
Materials and methods.
culture. IGF-I, PDGF and HGF had no significant effect on
the growth of OCUM-2M cells. TGF-,B decreased the growth
of OCUM-2M cells (Figure 5a). The growth effect was
evident after 72 h culture (Figure 5b).
Effect ofanti-growthfactor antibodies on the growth activity of
conditioned medium from gastricfibroblasts
To determine the relation between the growth activity of SF-
CM and the defined growth factors which stimulated
OCUM-2M cell growth, we tested whether neutralising
antibodies against EGF, b-FGF and PDGF-AA were able
to neutralise the growth-stimulating activity of the HPLC
fraction 22. Bioactivity of each antibody in OCUM-2M cells
was demonstrated in Table III. The growth activity of the
fraction was not inhibited by any neutralising antibody
(Table IV).
Discussion
In scirrhous gastric carcinoma, which is characterised by
extensive carcinoma cell infiltration and proliferation with
fibrosis, it is plausible that fibroblasts could affect the
progression of the cancer cells from the standpoint of its
characteristic histological findings. However, the growth
interaction between gastric cancer cells and gastric fibro-
blasts has not been reported. In the present study, we have
reported the organ-specific growth interaction between gastric
cancer cells and fibroblasts. Besides NF-I and NF-8, another
five stomach-derived fibroblast cell lines also significantly
stimulated the growth of scirrhous gastric cancer cells but not
well-differentiated adenocarcinoma cells (data not shown). It
was considered that gastric fibroblasts might specifically
stimulate the growth of scirrhous gastric cancer cells in a
Table IV Effect of neutralising antibodies against EGF, TGF-a,
b-FGF and VEGF on the growth activity of fraction 22a
Growth-promoting
activity
Antibody (% control) Inhibition (%)
Untreated 78 0
Mouse IgG
1 gml-' 80 0
10gml-, 72 8
25ggml-1 70 10
Rabbit IgG
lojigml- 75 4
25ggml-1 74 5
100 gml 69 12
Anti-EGF antibody
Ijgmi-' 76 3
Sggml-1 73 7
25jgmlr1 66 15
Anti-TGF-a antibody
10 ogml-l 77 1
25 igmlr1 71 9
100jigml-' 71 9
Anti-b-FGF antibody
1 gm1-1 80 0
5ggml'- 70 10
25jgmlr1 68 13
Anti-VEGF antibody
10ogml-1 79 0
25 gml- 80 0
lOOiggml-l 80 0
aNeutralising antibodies were mixed with the fractions 22 by HPLC,
which stimulated the growth ofOCUM-2M cells. The growth activity
was determined for OCUM-2M cells as described in Materials and
methods.
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general principle. The interactions between fibroblasts and
cancer cells, including breast cancer cells (Chiquet-Ehrismann
et al., 1989), melanoma cells (Enami et al., 1983; Horgan et
al., 1987; Cronil et al., 1991), lung cancer cells (Ankrapp and
Bevan, 1993), prostate cancer cells (Gleave et al., 1989) and
salivary adenocarcinoma cells (Shirasuma et al., 1988), have
been reported previously. In this study, however, it was
interesting that gastric cancer cells of varying differentiation
had differential responses to gastric fibroblasts. Most well-
differentiated adenocarcinoma cells proliferate in a medullary
pattern, while scirrhous gastric cancer cells proliferate
diffusely with extensive fibrosis (Japanese Research Society
for Gastric Cancer, 1995). This histological difference in the
volume of the stroma might be determined by the response of
gastric cancer cells to orthotopic fibroblasts.
The active molecule is considered to be a protein because
of its sensitivity to heat treatment and various proteinases.
The apparent molecular weight (Mr 10 000) of the growth
factor(s) produced from NF-8 cells was estimated by gel
filtration HPLC. It has been reported that the progression of
gastric carcinoma is associated with several growth factors
including EGF, TGF-a, b-FGF, VEGF, IGF-I, KGF, HGF,
PDGF and TGF-,B (Yoshida et al., 1990; Yasui et al., 1988;
Tanimoto et al., 1991; Hattori et al., 1994; Shibamoto et al.,
1992; Ito et al., 1992; Yoshida et al., 1989). Most scirrhous
gastric cancer cell lines are known to be stimulated by EGF,
b-FGF and KGF (Yoshida et al., 1990; Yasui et al., 1988;
Tanimoto et al., 1991; Hattori et al., 1994). The growth of
OCUM-2M cells was also stimulated by EGF, TGF-ax,
VEGF, b-FGF and KGF, but not IGF-I, PDGF, HGF
and TGF-fJ. In general, fibroblasts have been reported to
produce growth factors (Ankrapp et al., 1993; Hlatky et al.,
1994; Lawrence et al., 1984; Mooradian et al., 1992; Mukai et
al., 1989). We examined whether any of the defined growth
factors including EGF, VEGF, TGF-cL, b-FGF and KGF,
was the active factor in the conditioned medium from gastric
fibroblasts. However, the growth activity of the conditioned
medium was not decresed by neutralising antibody against
EGF, TGF-a, b-FGF and VEGF. In addition, no reactivity
with these antibodies in the active fraction was shown by
immunoblotting (data not shown). Conditioned medium
loaded onto a heparin affinity column had the growth-
promoting activity equal to that of the conditioned medium
before loading, which indicates that the heparin affinity
growth factors such as KGF, b-FGF and VEGF are distinct
from the growth activity present in SF-CM. Recently, more
than fifty cell growth factors have been evident. In this study,
only nine growth factors were examined; however, these
factors were almost included in all factors which had been
reported previously to be associated with the growth of
gastric cancer cells. These findings suggest that the growth
factor(s) produced by gastric fibroblasts might be different
from the defined factors known to be associated with the
progression of gastric carcinoma.
In conclusion, rapid proliferation of scirrhous gastric
carcinoma should be partly controlled by gastric fibroblasts.
There has been no previous report of a growth factor with
growth-promoting activity which depends on the histological
type of gastric cancer cells. The growth factior(s) produced
by gastric fibroblasts might be a unique factor(s) and may
play an important role in the progression of scirrhous gastric
cancer.
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